FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/14/2026
Back to search
Official data from USPTO
COFAZRY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
05/15/2026
Trademark type
Word
Nice classes
5
Filing date
02/21/2025
Registration date
04/14/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2026
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
NASSERGHODSI, SAHAR
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; immunomodulators; immunosuppressive agents; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2026
PUBO
PUBLISHED FOR OPPOSITION
02/24/2026
NPUB
NOTICE OF PUBLICATION
02/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2026
DOCK
ASSIGNED TO EXAMINER
01/30/2026
MAFR
APPLICATION FILING RECEIPT MAILED
01/29/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/29/2026
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/09/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/03/2025
Continuous trademark protection
Get notified about every new filing that threatens COFAZRY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.